Literature DB >> 8869331

Prognostic value of monolayer culture patterning in primary cell culture of oesophageal cancer.

Y Shimada1, Y Kanda, I Shibagaki, M Kato, G Watanabe, H Tanaka, M Kano, M Imamura.   

Abstract

The growth of primary cell cultures of oesophageal cancer was compared with the clinical outcome of patients from whom the cancers were taken. Ninety-three patients underwent curative resection, with no operative deaths, and were divided into three groups according to the monolayer culture pattern of the primary cell culture: culture from 43 patients (46 per cent) grew no malignant cells (group 1), 21 (23 per cent) produced monolayer epithelial growth (group 2) and the rest (from 29 patients) established cell lines (group 3). The 5-year survival rate of patients in group 2 (29 per cent) and group 3 (23 per cent) was significantly lower (P < 0.005) than that of those in group 1 (51 per cent). Monolayer epithelial growth potential is a significant prognostic factor in patients with oesophageal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8869331     DOI: 10.1002/bjs.1800830837

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Method to obtain endoscopic esophageal samples for primary cell culture: focus on infectious contamination.

Authors:  M Constant-Neto; M Falavigna; A C Castro; D C Machado
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy.

Authors:  Y Shimada; M Imamura; I Shibagaki; H Tanaka; T Miyahara; M Kato; K Ishizaki
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

Review 3.  Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved.

Authors:  Yutaka Shimada; Tetsuo Sudo; Shusuke Akamatsu; Takuro Sunada; Akira Myomoto; Kiyoshi Okano; Kazuharu Shimizu
Journal:  J Pers Med       Date:  2022-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.